Cargando…
Update on the Management of Aspirin-Exacerbated Respiratory Disease
Aspirin-exacerbated respiratory disease (AERD) is an adult-onset upper and lower airway disease consisting of eosinophilic nasal polyps, asthma, and respiratory reactions to cyclooxygenase 1 (COX-1) inhibitors. Management includes guideline-based treatment of asthma and sinus disease, avoidance of C...
Autores principales: | Buchheit, Kathleen M., Laidlaw, Tanya M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853506/ https://www.ncbi.nlm.nih.gov/pubmed/27126722 http://dx.doi.org/10.4168/aair.2016.8.4.298 |
Ejemplares similares
-
The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
por: Buchheit, Kathleen, et al.
Publicado: (2020) -
Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018) -
Aspirin-exacerbated respiratory disease: Update on medical management
por: White, Andrew A., et al.
Publicado: (2020) -
Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease
por: Palikhe, Nami Shrestha, et al.
Publicado: (2009) -
COVID-19 in a series of patients with aspirin-exacerbated respiratory disease
por: White, Andrew A., et al.
Publicado: (2021)